# A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

> **NCT00471380** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 46 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** travoprost 0.004% and brinzolamide 1%
- **DRUG:** fixed combination of timolol 0.5% and dorzolamide 2% plus travoprost vehicle

## Key facts

- **NCT ID:** NCT00471380
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2010-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471380, "A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00471380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*